Benztropine
(CPFJLLXFNPCTDW-UHFFFAOYSA-N)
Structure
- SMILES
- CS(=O)(=O)O.CN1C2CCC1CC(C2)OC(c1ccccc1)c1ccccc1
- Molecular Formula:
- C22H29NO4S
- Molecular Weight:
- 403.535
- Log P:
- 4.9405
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 1
- TPSA:
- 75.22
- CAS Number(s):
- 132-17-2; 102701-02-0
Synonym(s)
1.
Benztropine
2.
Apo-Benztropine
3.
Bensylate
4.
Benzatropine
5.
Benzatropine Mesylate
6.
Benzatropine Methanesulfonate
7.
Benzatropine Methanesulfonate, Hydrobromide
8.
Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer
9.
Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer
10.
Benztropine Mesylate
11.
Cogentin
12.
Cogentinol
13.
N-Methylbenztropine
14.
PMS-Benztropine
15.
Apo Benztropine
16.
Hydrobromide Benzatropine Methanesulfonate
17.
Mesylate, Benzatropine
18.
Mesylate, Benztropine
19.
Methanesulfonate, Benzatropine
20.
Methanesulfonate, Hydrobromide Benzatropine
21.
N Methylbenztropine
22.
PMS Benztropine
External Link(s)
| MeSH | D001590 |
| PubChem Compound | 238053 5351770 |
| CHEMBL | CHEMBL85236 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Completed Suicide | FAERS: 5 | US FAERS | |
| 2 | Anticholinergic Syndrome | FAERS: 3 | US FAERS | |
| 3 | Drug ineffective | FAERS: 3 | US FAERS | |
| 4 | Somnolence | FAERS: 3 | US FAERS | |
| 5 | Catatonia | FAERS: 2 | US FAERS | |
| 6 | Constipation | FAERS: 2 | US FAERS | |
| 7 | Hypersensitivity | FAERS: 2 | US FAERS | |
| 8 | Large intestine perforation | FAERS: 2 | US FAERS | |
| 9 | Nausea | FAERS: 2 | US FAERS | |
| 10 | Overdose | FAERS: 2 | US FAERS | |
| 11 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 12 | Tremor | FAERS: 2 | US FAERS | |
| 13 | Vasculitic rash | FAERS: 2 | US FAERS | |
| 14 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 15 | Abdominal tenderness | FAERS: 1 | US FAERS | |
| 16 | Dehydration | FAERS: 1 | US FAERS | |
| 17 | Delirium | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Disorientation | FAERS: 1 | US FAERS | |
| 19 | Dizziness | FAERS: 1 | US FAERS | |
| 20 | Dysphemia | FAERS: 1 | US FAERS | |
| 21 | Dysuria | FAERS: 1 | US FAERS | |
| 22 | Fatigue | FAERS: 1 | US FAERS | |
| 23 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 24 | Gingival erythema | FAERS: 1 | US FAERS | |
| 25 | Head titubation | FAERS: 1 | US FAERS | |
| 26 | Headache | FAERS: 1 | US FAERS | |
| 27 | Incoherent | FAERS: 1 | US FAERS | |
| 28 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 29 | Infectious peritonitis | FAERS: 1 | US FAERS | |
| 30 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 31 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 32 | Lethargy | FAERS: 1 | US FAERS | |
| 33 | Medication Error | FAERS: 1 | US FAERS | |
| 34 | Mental status changes | FAERS: 1 | US FAERS | |
| 35 | Monoplegia | FAERS: 1 | US FAERS | |
| 36 | Nervousness | FAERS: 1 | US FAERS | |
| 37 | Neuroleptic Malignant Syndrome | FAERS: 1 | US FAERS | |
| 38 | No adverse event | FAERS: 1 | US FAERS | |
| 39 | Oral pain | FAERS: 1 | US FAERS | |
| 40 | Physical product label issue | FAERS: 1 | US FAERS | |
| 41 | Post-Traumatic Stress Disorder | FAERS: 1 | US FAERS | |
| 42 | Product contamination | FAERS: 1 | US FAERS | |
| 43 | Product counterfeit | FAERS: 1 | US FAERS | |
| 44 | Product quality issue | FAERS: 1 | US FAERS | |
| 45 | Pruritus | FAERS: 1 | US FAERS | |
| 46 | Rash erythematous | FAERS: 1 | US FAERS | |
| 47 | Suicide attempt | FAERS: 1 | US FAERS | |
| 48 | Tardive Dyskinesia | FAERS: 1 | US FAERS | |
| 49 | Thirst | FAERS: 1 | US FAERS | |
| 50 | Urinary tract infection | FAERS: 1 | US FAERS | |
| 51 | Visual Impairment | FAERS: 1 | US FAERS | |
| 52 | Vomiting | FAERS: 1 | US FAERS | |
| 53 | Memory impairment | Canada Vigilance: 1 | Canada Vigilance | |
| 54 | Mental impairment | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.